FIELD: medicine, pharmaceutics.
SUBSTANCE: group of inventions refers to medicine and concerns methods of treating and diagnosing posttraumatic stress disorder in a patient, and also a method of intensifying an ability of the patient to experience a traumatic event herewith not suffering posttraumatic stress disorder. A therapeutically effective amount of (S)-5-aminomethyl-1-(5,7-difluoro-1,2;3,4-tetrahydronaphth-2-yl)-2,3-dihydro-2-thioxo-1H-imidazole (nepicastat), (R)-5-aminomethyl-1-(5,7-difluoro-1,2,3,4-tetrahydronaphth-2-yl)-2,3-dihydro-2-thioxo-1H-imidazole, their pharmaceutically acceptable salt or their mixture are introduced in the patient.
EFFECT: group of inventions provides the extended range of the methods of treating posttraumatic stress disorder.
18 cl, 187 dwg, 25 ex
| Title | Year | Author | Number |
|---|---|---|---|
| (4-METHOXY-7-MORPHOLIN-4-YL-BENZOTHIAZOL-2-YL)AMIDE 4-HYDROXY-4-METHYLPIPERIDINE-1-CARBOXYLIC ACID FOR TREATING POST-TRAUMATIC STRESS DISORDER | 2008 |
|
RU2500401C2 |
| METHOD OF TREATING ADDICTION | 2008 |
|
RU2491067C2 |
| CARBAMATE COMPOUND AND THE USE OF A COMPOSITION CONTAINING IT FOR THE PREVENTION, RELIEF OR TREATMENT OF ACUTE STRESS DISORDER OR POST-TRAUMATIC STRESS DISORDER | 2019 |
|
RU2796295C2 |
| TREATMENT OF POST-TRAUMATIC STRESS DISORDER WITH ISOLATED MYCOBACTERIUM | 2013 |
|
RU2670751C9 |
| METHODS OF TREATMENT OF BIPOLAR DISORDER | 2011 |
|
RU2653408C2 |
| METHOD OF TREATING POST-TRAUMATIC STRESS DISORDER USING THERAPEUTIC FACTORS OF RESORT "NALCHIK" | 2023 |
|
RU2821648C1 |
| PREVENTIVE AND THERAPEUTIC AGENT FOR ATTENTION DEFICIT HYPERACTIVITY DISORDER | 2014 |
|
RU2708694C2 |
| METHOD FOR PHENOTYPE DETERMINATION OF STRESSED RATS WITH SIMULATED PHOBIC ANXIETY DISORDER | 2024 |
|
RU2830034C1 |
| PSYCHOTIC DISORDER SIMULATION METHOD | 2004 |
|
RU2366464C2 |
| COMPOUND FOR USE IN TREATING NEUROGENIC ORTHOSTATIC HYPOTENSION | 2017 |
|
RU2723095C1 |
